one-year weight reduction with semaglutide or liraglutide in clinical practice Long-term loss effects of obesity without diabetes in the SELECT trial Semaglutide results week by week:

Under NICE TA875, it is recommended for adults with a BMI of 35 kg/m and at least one weight-related comorbidity (or BMI 3034.9 kg/m in defined circumstances), when used as part of a specialist weight management service Liraglutide 3 mg (Saxenda) holds a UK marketing authorisation for weight management

Nassar M, et al

Semaglutide Yields Significant Body Composition Improvements They found treatment with semaglutide improved body composition by reducing excess body fat, including abdominal fat, and increasing the proportion of lean body mass, or the amount of weight someone carries that is not body fat

However, in some instances, improvement can be possible in three months

The initial search yielded 564 articles